Medications for addiction treatment initiated from the emergency department: Ethical considerations

Kenneth D Marshall; Arthur R Derse; Kenneth V Iserson; Nicholas Kluesner; Laura Vearrier

doi:10.1016/j.ajem.2019.09.022

Medications for addiction treatment initiated from the emergency department: Ethical considerations

Am J Emerg Med. 2020 Feb;38(2):343-348. doi: 10.1016/j.ajem.2019.09.022. Epub 2019 Nov 16.

Authors

Kenneth D Marshall¹, Arthur R Derse², Kenneth V Iserson³, Nicholas Kluesner⁴, Laura Vearrier⁵

Affiliations

¹ Department of Emergency Medicine and Department of History and Philosophy of Medicine, University of Kansas Medical Center. Kansas City, KS, USA. Electronic address: [email protected].
² Center for Bioethics and Medical Humanities, Institute for Health and Society, and Department of Emergency Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
³ Department of Emergency Medicine, University of Arizona, Tucson, AZ, USA; Department of Emergency Medicine, Georgetown Public Hospital, Georgetown, Guyana.
⁴ UnityPoint Health, Des Moines, IA, USA; Department of Emergency Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
⁵ Department of Emergency Medicine, College of Medicine, Drexel University, Philadelphia, PA, USA.

PMID: 31831343
DOI: 10.1016/j.ajem.2019.09.022

No abstract available

Keywords: Emergency; Harm reduction; MAT; MOUD; Medication assisted treatment; Medications for addiction treatment; Medications for opioid use disorder; Opioid.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Buprenorphine / therapeutic use
Emergency Service, Hospital*
Harm Reduction
Humans
Opiate Substitution Treatment / ethics*
Opioid-Related Disorders / diagnosis*
Opioid-Related Disorders / drug therapy*
United States

Substances

Buprenorphine